Entero Healthcare Financials
| ENTERO Stock | 1,137 0.40 0.04% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1 B | 998.5 M |
|
|
Entero | Select Account or Indicator |
Understanding current and past Entero Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Entero Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Entero Healthcare's assets may result in an increase in income on the income statement.
Please note, the presentation of Entero Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Entero Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Entero Healthcare's management manipulating its earnings.
Entero Healthcare Stock Summary
Entero Healthcare competes with Dev Information, GM Breweries, Tata Communications, Bank of Maharashtra, and Som Distilleries. Entero Healthcare is entity of India. It is traded as Stock on NSE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE010601016 |
| Business Address | Trade Centre, Bandra |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.enterohealthcare.com |
| Phone | 91 22 6901 9100 |
You should never invest in Entero Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Entero Stock, because this is throwing your money away. Analyzing the key information contained in Entero Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Entero Healthcare Key Financial Ratios
Entero Healthcare's financial ratios allow both analysts and investors to convert raw data from Entero Healthcare's financial statements into concise, actionable information that can be used to evaluate the performance of Entero Healthcare over time and compare it to other companies across industries.| Revenue | 39.22 B | ||||
| Gross Profit | 4.44 B | ||||
| EBITDA | 1.21 B | ||||
| Net Income | 355.55 M | ||||
| Total Asset | 23.45 B |
Entero Healthcare Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 8.3B | 11.3B | 14.0B | 23.4B | 27.0B | 14.2B | |
| Other Current Liab | 379.8M | 609.5M | 539.0M | 1.2B | 1.4B | 731.9M | |
| Net Debt | 1.7B | 3.1B | 4.4B | 1.9B | 2.2B | 2.7B | |
| Retained Earnings | (318.5M) | (618.0M) | (727.0M) | (338.1M) | (304.3M) | (319.5M) | |
| Accounts Payable | 967.4M | 1.4B | 2.1B | 2.3B | 2.6B | 1.7B | |
| Cash | 323.1M | 465.1M | 253.6M | 1.5B | 1.7B | 1.8B | |
| Net Receivables | 2.5B | 3.8B | 5.2B | 6.5B | 7.5B | 4.5B | |
| Good Will | 894.9M | 1.5B | 2.0B | 1.9B | 2.2B | 1.6B | |
| Inventory | 2.4B | 3.1B | 3.6B | 4.2B | 4.8B | 3.4B | |
| Other Current Assets | 3.1B | 4.4B | 480.2M | 8.0B | 9.2B | 9.7B | |
| Total Liab | 3.5B | 5.6B | 7.8B | 7.0B | 8.1B | 6.0B | |
| Total Current Assets | 6.3B | 8.5B | 10.9B | 20.1B | 23.1B | 24.3B | |
| Short Term Debt | 1.5B | 2.6B | 3.6B | 2.4B | 2.8B | 2.5B | |
| Intangible Assets | 46.0M | 44.5M | 38.4M | 34.4M | 39.5M | 42.1M | |
| Common Stock | 1M | 38.5M | 342.6M | 434.9M | 500.2M | 525.2M |
Entero Healthcare Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Revenue | 17.7B | 25.2B | 33.0B | 39.2B | 45.1B | 28.3B | |
| Gross Profit | 1.3B | 2.0B | 2.7B | 3.5B | 4.0B | 2.3B | |
| Operating Income | 69.5M | 125.3M | 452.8M | 868.3M | 998.5M | 1.0B | |
| Ebit | 91.8M | 62.8M | 452.4M | 960.4M | 1.1B | 1.2B | |
| Ebitda | 254.6M | 260.4M | 694.8M | 1.2B | 1.4B | 1.5B | |
| Cost Of Revenue | 16.4B | 23.1B | 30.3B | 35.7B | 41.1B | 26.0B | |
| Income Before Tax | (108.4M) | (198.1M) | (36.9M) | 355.6M | 408.9M | 429.3M | |
| Net Income | (155.4M) | (299.2M) | (115.6M) | 391.1M | 449.8M | 472.2M | |
| Income Tax Expense | 45.2M | 96.3M | 74.2M | (42.4M) | (38.2M) | (36.3M) |
Entero Healthcare Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Entero Healthcare. It measures of how well Entero is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Entero Healthcare brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Entero had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Entero Healthcare has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (489.5M) | (301.0M) | (193.9M) | (581.8M) | (523.6M) | (549.8M) | |
| Change In Cash | (108.4M) | 141.9M | (211.5M) | 1.2B | 1.4B | 1.5B | |
| Free Cash Flow | (782.1M) | (451.3M) | (508.3M) | (420.3M) | (483.3M) | (507.5M) | |
| Change In Working Capital | (959.3M) | (460.7M) | (1.0B) | (1.5B) | (1.3B) | (1.4B) | |
| Begin Period Cash Flow | 431.5M | 323.1M | 465.1M | 253.6M | 228.3M | 341.6M | |
| Other Cashflows From Financing Activities | 534.8M | 641.2M | (159.9M) | (383.0M) | (344.7M) | (327.4M) | |
| Depreciation | 162.8M | 197.5M | 242.4M | 250.2M | 287.7M | 212.8M | |
| Other Non Cash Items | 173.9M | 255.4M | 448.8M | 467.8M | 537.9M | 404.7M | |
| Capital Expenditures | 95.3M | 98.7M | 55.2M | 54.2M | 48.7M | 46.3M | |
| Total Cash From Operating Activities | (686.8M) | (352.7M) | (453.2M) | (366.1M) | (421.0M) | (442.1M) | |
| Change To Account Receivables | (119.2M) | (682.2M) | (1.3B) | (667.2M) | (600.5M) | (630.5M) | |
| Net Income | (108.4M) | (198.1M) | (36.9M) | 355.6M | 408.9M | 429.3M | |
| Total Cash From Financing Activities | 887.1M | 2.1B | 727.6M | 8.6B | 9.9B | 10.4B | |
| End Period Cash Flow | 323.1M | 465.1M | 253.6M | 1.5B | 1.7B | 1.8B | |
| Other Cashflows From Investing Activities | (228.5M) | (83.8M) | (225.9M) | 102.0M | 117.3M | 123.1M |
Entero Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Entero Healthcare's current stock value. Our valuation model uses many indicators to compare Entero Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entero Healthcare competition to find correlations between indicators driving Entero Healthcare's intrinsic value. More Info.Entero Healthcare Solutions is one of the top stocks in profit margin category among its peers. It also is one of the top stocks in operating margin category among its peers reporting about 1.64 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Entero Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Entero Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Entero Healthcare Systematic Risk
Entero Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Entero Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Entero Healthcare correlated with the market. If Beta is less than 0 Entero Healthcare generally moves in the opposite direction as compared to the market. If Entero Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Entero Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Entero Healthcare is generally in the same direction as the market. If Beta > 1 Entero Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Entero Healthcare Solutions Total Assets Over Time
Entero Healthcare Thematic Clasifications
Entero Healthcare Solutions is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasEntero Healthcare March 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Entero Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Entero Healthcare Solutions. We use our internally-developed statistical techniques to arrive at the intrinsic value of Entero Healthcare Solutions based on widely used predictive technical indicators. In general, we focus on analyzing Entero Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Entero Healthcare's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 12.34 | |||
| Value At Risk | (3.60) | |||
| Potential Upside | 3.21 |
Complementary Tools for Entero Stock analysis
When running Entero Healthcare's price analysis, check to measure Entero Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entero Healthcare is operating at the current time. Most of Entero Healthcare's value examination focuses on studying past and present price action to predict the probability of Entero Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entero Healthcare's price. Additionally, you may evaluate how the addition of Entero Healthcare to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |